How do we measure the value of and pay for biomedical innovation?
Dana Goldman, Samuel Nussbaum, and Mark Linthicum have an interesting post on the Health Affairs blog about innovation, value measurement and pricing. The article mentions the new Innovation and Value Initiative, where I serve as the Director of Research. An excerpt is below. New pricing mechanisms are needed to effectively link prices to value; we…